Neutrophil activator of matrix metalloproteinase-2 (NAM)

Author： Rollo Ellen Hymowitz Michelle Schmidt Cathleen Montana Steve Foda Hussein Zucker Stanley

ISSN： 0262-0898

Source： Clinical and Experimental Metastasis, Vol.23, Iss.5-6, 2006-11, pp. : 259-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The p75^NTR metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells

By Nalbandian Angèle Djakiew Daniel

Clinical and Experimental Metastasis, Vol. 23, Iss. 2, 2006-04 ,pp. : 107-116

Springer Publishing Company

Access to resources Recommend Favorite

The plasminogen activator and matrix metalloproteinase systems in colorectal cancer - relationship to tumour pathology

By Baker E.A. Leaper D.J.

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 981-988

Elsevier

Access to resources Recommend Favorite

Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis

Biomedical Reports, Vol. 3, Iss. 4, 2015-01 ,pp. : 559-565

Science Publishers

Access to resources Recommend Favorite

Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer

By Sivula Anna

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 215-220

Springer Publishing Company

Access to resources Recommend Favorite

Matrix metalloproteinase2 and 9 and tissue inhibitor of metalloproteinase1 and 2 in sera and urine of patients with renal carcinoma

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 621-626

Spandidos Publications

Access to resources Recommend Favorite